Serum gangliosides as endogenous immunomodulators.
Gangliosides suppress various immune activities in vitro and in vivo. Their level is significantly elevated in tumors and atherosclerotic aorta tissue, as well as in the sera of patients with tumors or atherosclerosis. Here, Lev Bergelson suggests that ganglioside-induced immunomodulation might be involved in atherogenesis and carcinogenesis, and describes a hypothesis that cites gangliosides as a factor interfering with the clearance of low-density lipoproteins (LDLs) and promoting the formation of atherosclerotic plaques.
Bergelson
L D
LD
School of Pharmacy, Hebrew University of Jerusalem, Ein Kerem, Israel.
D000818:Animals; D001161:Arteriosclerosis / Q000276:immunology; D005732:Gangliosides / Q000097:blood* / Q000276:immunology*; D006801:Humans; D009369:Neoplasms / Q000276:immunology
D005732:Gangliosides